end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightOutstanding,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConvertibleDebtCurrent,DeferredCosts,DeferredCostsCurrentAndNoncurrent,DilutiveSecuritiesEffectOnBasicEarningsPerShareOther,EarningsPerShareBasic,EarningsPerShareDiluted,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueAdjustmentOfWarrants,GainsLossesOnExtinguishmentOfDebt,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpense,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermNotesPayable,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NetIncomeLossAvailableToCommonStockholdersDiluted,NonoperatingIncomeExpense,NotesPayableCurrent,NumberOfOperatingSegments,OperatingIncomeLoss,PaidInKindInterest,PaymentsOfStockIssuanceCosts,PaymentsToAcquireInProcessResearchAndDevelopment,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromConvertibleDebt,ProceedsFromIssuanceOfOtherLongTermDebt,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,ResearchAndDevelopmentInProcess,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,StockholdersEquity,StockIssued1,StockIssuedDuringPeriodSharesIssuedForServices,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueShareBasedCompensationGross,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityParOrStatedValuePerShare,UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic,UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted,WeightedAverageNumberDilutedSharesOutstandingAdjustment,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfSharesOutstandingBasic,AccruedProfessionalFeesCurrent,ConversionOfStockAmountConverted1,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPrepaidExpenses,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EffectiveIncomeTaxRateReconciliationTaxExemptIncome,EmployeeRelatedLiabilitiesCurrent,IncomeTaxExpenseBenefit,LeaseAndRentalExpense,OtherAccruedLiabilitiesCurrent,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromRelatedPartyDebt,RestrictedCash,RestrictedCashNoncurrent,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities,TemporaryEquitySharesAuthorized,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,ValuationAllowanceDeferredTaxAssetChangeInAmount
2021-09-30,2021-12-02,10-Q,CONTEXT THERAPEUTICS INC.,CNTX,CIK0001842952,USD,3083420.0,1325194.0,2948294.0,,,5787116.0,2259304.0,437531.0,419152.0,419152.0,,480415.0,0.001,100000000.0,348531.0,348531.0,348.0,0.0,1821773.0,1800000.0,0.0,-4.0,-4.0,1400000.0,,,828464.0,,,,1261.0,4408614.0,2259304.0,4408614.0,0.0,,,,-1442792.0,-1442792.0,-1442792.0,126531.0,0.0,,-1568062.0,,,,18379.0,,,739598.0,0.0,-26162575.0,,90765.0,8.08,,,436437.0,5.69,436437.0,5.69,,-23213933.0,,,,161823.0,21064623.0,0.001,0.0,0.0,0.0,361067.0,361067.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
